Selling Science

Polio and the Promise of Gamma Globulin

Nonfiction, Health & Well Being, Medical, Reference, History, Science & Nature, Science, Other Sciences
Cover of the book Selling Science by Stephen E. Mawdsley, Rutgers University Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Stephen E. Mawdsley ISBN: 9780813574400
Publisher: Rutgers University Press Publication: August 1, 2016
Imprint: Rutgers University Press Language: English
Author: Stephen E. Mawdsley
ISBN: 9780813574400
Publisher: Rutgers University Press
Publication: August 1, 2016
Imprint: Rutgers University Press
Language: English

Today, when many parents seem reluctant to have their children vaccinated, even with long proven medications, the Salk vaccine trial, which enrolled millions of healthy children to test an unproven medical intervention, seems nothing short of astonishing. In Selling Science, medical historian Stephen E. Mawdsley recounts the untold story of the first large clinical trial to control polio using healthy children—55,000 healthy children—revealing how this long-forgotten incident cleared the path for Salk’s later trial.

 

Mawdsley describes how, in the early 1950s, Dr. William Hammon and the National Foundation for Infantile Paralysis launched a pioneering medical experiment on a previously untried scale. Conducted on over 55,000 healthy children in Texas, Utah, Iowa, and Nebraska, this landmark study assessed the safety and effectiveness of a blood component, gamma globulin, to prevent paralytic polio. The value of the proposed experiment was questioned by many prominent health professionals as it harbored potential health risks, but as Mawdsley points out, compromise and coercion moved it forward. And though the trial returned dubious results, it was presented to the public as a triumph and used to justify a federally sanctioned mass immunization study on thousands of families between 1953 and 1954. Indeed, the concept, conduct, and outcome of the GG study were sold to health professionals, medical researchers, and the public at each stage. At a time when most Americans trusted scientists, their mutual encounter under the auspices of conquering disease was shaped by politics, marketing, and at times, deception.

Drawing on oral history interviews, medical journals, newspapers, meeting minutes, and private institutional records, Selling Science sheds light on the ethics of scientific conduct, and on the power of marketing to shape public opinion about medical experimentation.

 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Today, when many parents seem reluctant to have their children vaccinated, even with long proven medications, the Salk vaccine trial, which enrolled millions of healthy children to test an unproven medical intervention, seems nothing short of astonishing. In Selling Science, medical historian Stephen E. Mawdsley recounts the untold story of the first large clinical trial to control polio using healthy children—55,000 healthy children—revealing how this long-forgotten incident cleared the path for Salk’s later trial.

 

Mawdsley describes how, in the early 1950s, Dr. William Hammon and the National Foundation for Infantile Paralysis launched a pioneering medical experiment on a previously untried scale. Conducted on over 55,000 healthy children in Texas, Utah, Iowa, and Nebraska, this landmark study assessed the safety and effectiveness of a blood component, gamma globulin, to prevent paralytic polio. The value of the proposed experiment was questioned by many prominent health professionals as it harbored potential health risks, but as Mawdsley points out, compromise and coercion moved it forward. And though the trial returned dubious results, it was presented to the public as a triumph and used to justify a federally sanctioned mass immunization study on thousands of families between 1953 and 1954. Indeed, the concept, conduct, and outcome of the GG study were sold to health professionals, medical researchers, and the public at each stage. At a time when most Americans trusted scientists, their mutual encounter under the auspices of conquering disease was shaped by politics, marketing, and at times, deception.

Drawing on oral history interviews, medical journals, newspapers, meeting minutes, and private institutional records, Selling Science sheds light on the ethics of scientific conduct, and on the power of marketing to shape public opinion about medical experimentation.

 

More books from Rutgers University Press

Cover of the book Imperial Affects by Stephen E. Mawdsley
Cover of the book A Hundred Acres of America by Stephen E. Mawdsley
Cover of the book Into Africa by Stephen E. Mawdsley
Cover of the book Abstinence Cinema by Stephen E. Mawdsley
Cover of the book Children and Drug Safety by Stephen E. Mawdsley
Cover of the book American Hybrid Poetics by Stephen E. Mawdsley
Cover of the book Acting by Stephen E. Mawdsley
Cover of the book Our Caribbean Kin by Stephen E. Mawdsley
Cover of the book After Capitalism by Stephen E. Mawdsley
Cover of the book Technology and Engagement by Stephen E. Mawdsley
Cover of the book Troubling Nationhood in U.S. Latina Literature by Stephen E. Mawdsley
Cover of the book War Echoes by Stephen E. Mawdsley
Cover of the book Black Movements by Stephen E. Mawdsley
Cover of the book Thieving Three-Fingered Jack by Stephen E. Mawdsley
Cover of the book Junctures in Women's Leadership by Stephen E. Mawdsley
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy